期刊
VIRUSES-BASEL
卷 14, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/v14071507
关键词
SARS-CoV-2; COVID-19; cell model; animal model; drug
类别
This article reviews the information on available SARS-CoV-2 preclinical models and discusses their development, advantages, drawbacks, and relevance to drug effectiveness evaluation.
During the last two years following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, development of potent antiviral drugs and vaccines has been a global health priority. In this context, the understanding of virus pathophysiology, the identification of associated therapeutic targets, and the screening of potential effective compounds have been indispensable advancements. It was therefore of primary importance to develop experimental models that recapitulate the aspects of the human disease in the best way possible. This article reviews the information concerning available SARS-CoV-2 preclinical models during that time, including cell-based approaches and animal models. We discuss their evolution, their advantages, and drawbacks, as well as their relevance to drug effectiveness evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据